Literature DB >> 9301524

Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway.

N Benbernou1, S Esnault, H C Shin, H Fekkar, M Guenounou.   

Abstract

Expression of cytokines by T lymphocytes is a highly balanced process, involving stimulatory and inhibitory intracellular signalling pathways. In the present work, we attempted to clarify the role of cAMP on interferon-gamma (IFN-gamma), interleukin (IL)-10, IL-4 and IL-13 expression as well as on the inducible nitric oxide synthase (iNOS) expression. Treatment of phytohaemagglutinin (PHA)/phorbol 12-myristate 13-acetate (PMA)-activated Jurkat cells with either dibutyryl-cyclic adenosine monophosphate (cAMP) or pentoxifylline induced a strong inhibition of IFN-gamma mRNA expression as measured by reverse transcription (RT)-polymerase chain reaction (PCR), without affecting IL-10 expression. Both cholera toxin and prostaglandin E2 (PGE2) induced a strong inhibition of IFN-gamma mRNA expression, whereas IL-10 mRNA expression was significantly enhanced. This differential regulation of IFN-gamma and IL-10 expression was related to intracellular cAMP concentration. IL-13 and IL-4 mRNA expressions were not inhibited. We developed a new method based on immunofluorescence for intracellular cytokine detection followed by optical and computerized image processing, and our results showed that IFN-gamma protein was strongly inhibited when cells were treated with PGE2 or dibutyryl (db)-cAMP, whereas IL-10 protein was enhanced. This suggests that cAMP exerts its action at both the transcriptional and protein levels. iNOS mRNA expression was markedly elevated in the presence of PGE2. The generation of nitric oxide using sodium nitroprusside (SNP) induced a dramatic decrease of IFN-gamma, while IL-10 was enhanced; and conversely the inhibition of iNOS activity using 1-NG-monomethyl arginine (1-NMMA) induced a clear inhibition of IL-10 and IL-4, while IFN-gamma was enhanced. These results provide evidence that the protein kinase A (PKA) activation pathway plays a prominent role in the balance between the type 1 and type 2 cytokine profile in PHA/PMA-activated Jurkat cells. Data also suggest that iNOS expression is under the control of PKA activation, and that NO seems to be able to assume the polarization of activated T cells to the type 2 profile.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9301524      PMCID: PMC1364004          DOI: 10.1046/j.1365-2567.1997.00260.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  37 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis.

Authors:  T Jakob; B N Huspith; Y E Latchman; R Rycroft; J Brostoff
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

3.  Studies on the cyclic AMP response to prostaglandin in human lymphocytes.

Authors:  J S Goodwin; S Bromberg; R P Messner
Journal:  Cell Immunol       Date:  1981-05-15       Impact factor: 4.868

4.  Altered leukocyte protein kinase activity in atopic dermatitis.

Authors:  D M Trask; S C Chan; S E Sherman; J M Hanifin
Journal:  J Invest Dermatol       Date:  1988-04       Impact factor: 8.551

5.  cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells.

Authors:  T J Novak; E V Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.

Authors:  M Betz; B S Fox
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

7.  Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3':5'-cyclic monphosphate and its derivatives.

Authors:  G S Johnson; R M Friedman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

Review 8.  Lymphokine production by human T cells in disease states.

Authors:  S Romagnani
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

9.  Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.

Authors:  D J Stuehr; C F Nathan
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation.

Authors:  E Muñoz; A M Zubiaga; M Merrow; N P Sauter; B T Huber
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  25 in total

1.  Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD-1, by cyclic AMP.

Authors:  M Cavicchi; B J Whittle
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Thymic stromal lymphopoietin (TSLP) as a bridge between infection and atopy.

Authors:  Stéphane Esnault; Louis A Rosenthal; Deng-Shun Wang; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

3.  Differential inhibitory mechanism of cyclic AMP on TNF-alpha and IL-12 synthesis by macrophages exposed to microbial stimuli.

Authors:  D O Procópio; M M Teixeira; M M Camargo; L R Travassos; M A Ferguson; I C Almeida; R T Gazzinelli
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 4.  Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells.

Authors:  Wesley M Jackson; Leon J Nesti; Rocky S Tuan
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

5.  Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection.

Authors:  S Schweyer; S Mihm; H J Radzun; H Hartmann; A Fayyazi
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

6.  Role of increased guanosine triphosphate cyclohydrolase-1 expression and tetrahydrobiopterin levels upon T cell activation.

Authors:  Wei Chen; Li Li; Torben Brod; Omar Saeed; Salim Thabet; Thomas Jansen; Sergey Dikalov; Cornelia Weyand; Jorg Goronzy; David G Harrison
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

7.  Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells.

Authors:  Matthew J Loza; Susan Foster; Stephen P Peters; Raymond B Penn
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

8.  Effects of intrinsic nitric oxide on the expression of interleukin-4 and IFN-gamma mRNA in the bronchial and lung tissues of sensitized rats.

Authors:  J Xue; Y Xu; Z Zhang
Journal:  J Tongji Med Univ       Date:  2000

9.  cAMP activates the generation of reactive oxygen species and inhibits the secretion of IL-6 in peripheral blood mononuclear cells from type 2 diabetic patients.

Authors:  Camila Armond Isoni; Erica Abreu Borges; Clara Araújo Veloso; Rafael Teixeira Mattos; Miriam Martins Chaves; José Augusto Nogueira-Machado
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

10.  Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator.

Authors:  Lamis Jarvinen; Linda Badri; Scott Wettlaufer; Takashi Ohtsuka; Theodore J Standiford; Galen B Toews; David J Pinsky; Marc Peters-Golden; Vibha N Lama
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.